Iron status and the risk of coronary heart disease

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 9, Issue 6, 1999, Pages 294-303

  Sempos, C T ^a,c   Looker, A C ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Coronary heart disease; Epidemiology; Ferritin; Heart disease; Iron

Indexed keywords

FERRITIN; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANSFERRIN;

BLOOD; BLOOD DONOR; CORONARY ARTERY DISEASE; DIET; HUMAN; METABOLISM; REVIEW; RISK FACTOR;

BLOOD DONORS; CHOLESTEROL, LDL; CORONARY DISEASE; DIET; FERRITINS; HUMANS; IRON; RISK FACTORS; TRANSFERRIN;

EID: 0033290948     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. Sullivan JL (1981) Iron and the sex difference in heart disease risk. Lancet 1: 1293-1294
2. Sullivan JL (1989) The iron paradigm of ischemic heart disease. Am Heart J 117: 1177-1188
3. Sullivan JL (1983) The sex difference in ischemic heart disease. Perspect Biol Med 26: 657-671
4. Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R (1992) High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86: 803-811
5. Halliwell B, Chirico S (1993) Lipid peroxidation: its mechanism, measurement and significance. Am J Clin Nutr 57 (suppl): 715s-725s
6. Reaven PD, Wiztum JL (1996) Oxidized low density lipoproteins in atherogenesis: role of dietary modification. Ann Rev Nutr 16: 51-71
7. Steinberg D (1997) Oxidative modification of LDL and atherogenesis. Circulation 95: 1062-1071
8. Yuan XM, Brunk UT (1998) Iron and LDL-oxidation in atherogenesis. APMIS 106: 825-842
9. Heinecke JW (1998) Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 141: 1-5
10. Danesh J, Appleby P (1999) Coronary heart disease and iron status. Meta-analysis of prospective studies. Circulation 99: 852-854
11. Expert Scientific Working Group (1985) Summary of a report on assessment of the iron nutritional status of the United States population. Am J Clin Nutr 42: 1318-1330
12. Lipschitz DA, Cook JD, Finch CA (1974) A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med 290: 1213-1216
13. Sempos CT, Looker AC, Gillum RF, Makuc DM (1994) Body iron stores and the risk of coronary heart disease [Reply]. N Engl J Med 331: 1160
14. Bothwell T, Charlton R, Cook J, Finch C (1979) Iron metabolism in man. Blackwell Scientific, Oxford, England
15. Herbert V (1992) Everyone should be tested for iron disorders. J Am Diet Assoc 92: 1502-1509
16. Custer EM, Finch CA, Sobel RE, Zettner A (1995) Population norms for serum ferritin. J Lab Clin Med 126: 88-94
17. Hulthén L, Lindstedt G, Lundberg P-A, Hallberg L (1998) Effect of a mild infection on serum ferritin concentration - clinical and epidemiological implications. Eur J Clin Nutr 52: 376-379
18. Yip R, Dallman PR (1988) The roles of inflammation and iron deficiency as causes of anemia. Am J Clin Nutr 48: 1295-1300
19. Birgegård G, Hällgren R, Venge P, Wide L (1979) Serum ferritin during inflammation. A study on myocardial infarction. Acta Med Scand 206: 361-366
20. Griffiths JD, Campbell LJ, Woodruff IW, Cruickshank D, Mathews YB, Hunt D, Campbell DG, Cowling DC (1985) Acute changes in iron metabolism following myocardial infarction. Am J Clin Pathol 84: 649-654
21. van der Schouw YT, van der Veeken PMWC, Kok FJ, Koster JF, Schouten EG, Hofman A (1990) Iron status in the acute phase and six weeks after myocardial infarction. Free Radic Biol Med 8: 47-53
22. Salonen JT, Nyyssönen K, Salonen R (1994) Body iron stores and the risk of coronary heart disease [Letter]. N Engl J Med 331: 1159
23. Toumainen TP, Punnonen K, Nyyssönen K, Salonen JT (1998) Association between body iron stores and the risk of acute myocardial infarction. Circulation 1461-1466
24. Clayton D, Hills M (1993) Statistical Models in Epidemiology. Oxford University Press, Oxford
25. Magnusson MK, Sigfusson N, Sigvaldason H, Johannesson GM, Magnusson S, Thorgeirsson G (1994) Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 89: 102-108
26. Stampfer MJ, Grodstein F, Rosenberg I, Willett W, Hennekens C (1993) A prospective study of plasma ferritin and risk of myocardial infarction in US physicians [Abstract] Circulation 87: 688
27. Mänttäri M, Manninen V, Huttunen JK, Palosno T, Ehnholm C, Heinonen OP, Frick MH et al (1994) Serum ferritin and ceruloplasmin as coronary risk factors. Eur Heart J 15: 1599-1603
28. Frey GH, Krider DW (1994) Serum ferritin and myocardial infarct. W V Med J 90: 13-15
29. Kiechl S, Willeit J, Egger G, Poewe W, Oberholenzer F (1997) Body iron stores and the risk of carotid atherosclerosis. Circulation 96: 3300-3307
30. Aronow WS, Ahn C (1996) Three-year follow-up shows no association of serum ferritin levels with incidence of new coronary events in 577 persons aged ≥62 years. Am J Cardiol 78: 678-679
31. Beaglehole R, Bonita R, Kjellström T (1993) Basic epidemiology. World Health Organization, Geneva
32. Gordis L (1996) Epidemiology. WB Saunders Co, Philadelphia
33. Aronow WS (1993) Serum ferritin is not a risk factor for coronary artery disease in men and women aged ≥62 years. Am J Cardiol 72: 347-348
34. Solymoss BC, Marcil M, Gilfix BM, Gelinas F, Poitras AM, Campeau L (1994) The place of ferritin among risk factors associated with coronary artery disease. Coron Artery Dis 5: 231-235
35. Rauramaa R, Väisänen S, Mercuri M, Rankinen T, Penttila I, Bond MG (1994) Association of risk factors and body iron status to carotid atherosclerosis in middle-aged Eastern Finnish men. Eur Heart J 15: 1020-1027
36. Kiechl S, Aichner F, Gerstenbrand F, Egger G, Mair A, Rungger G, Spögler F, Jarosch E, Oberhollenzer F, Willeit J, et al (1994) Body iron stores and presence of carotid atherosclerosis. Results from the Bruneck Study. Arterioscler Thromb 14: 1625-1630
37. Duthie GG, Beattie JAG, Arthur JR, Franklin M, Morrice PC, James WPT (1994) Blood antioxidants and indices of lipid peroixidation in subjects with stable angina. Nutrition 10: 313-316
38. Rengström J, Tonrvall P, Kallner A, Nilsson J, Hamsten A (1994) Stored iron levels and myocardial infarction at a young age. Atherosclerosis 106: 123-125
39. Moore M, Folsom AR, Barnes RW, Eckfeldt JH (1995) No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 141: 719-723
40. van der Schouw YT, Verbeek A, Ruijs J (1992) ROC curves for the initial assessment of new diagnostic tests. Fam Pract 9: 506-511
41. Eichner JE, Qi H, Moorre WE, Schechter E (1998) Iron measures in coronary angiography patients. Atherosclerosis 136: 241-245
42. Endbergs A, Dorzewski A, Luft M, Münnig G, Kleemann A, Schulte H, Assmann G, Breithhardt G, Kerber S (1998) Failure to confirm ferritin and caeruloplasmin as risk factors for the angiographic extent of coronary atherosclerosis. Coron Artery Dis 9: 119-124
43. Sempos CT, Looker AC, Gillum RF, Makuc DM (1994) Body iron stores and the risk of coronary heart disease. N Engl J Med 330: 1119-1124
44. Liao Y, Cooper RS, McGee DL (1994) Iron status and coronary heart disease: Negative findings from the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 139: 704-712
45. Baer DM, Tekawa IS, Hurley LB (1994) Iron stores are not associated with acute myocardial infarction. Circulation 89: 2915-2918
46. Reunanen A, Takkunen H, Knekt P, Sappänen R, Aromaa A (1995) Body iron stores, dietary iron intake and coronary heart disease mortality. J Intern Med 238: 223-230
47. van Asperen IA, Feskens EJM, Bowels CH, Kromhout D (1995) Body iron stores and mortality due to cancer and ischemic heart disease: A 17-year follow-up study of elderly men and women. Int J Epidemiol 24: 665-670
48. Morrison HI, Semenciw RM, Mao Y, Wigle DT (1994) Serum iron and fatal acute myocardial infarction. Epidemiology 5: 243-246
49. Corti MC, Guralnik JM, Salvie ME, Ferrucci L, Pahor M, Wallace RB, Hennekens CH (1997) Serum iron level, coronary artery disease, and all cause mortality in older men and women. Am J Cardiol 79: 120-127
50. Ascherio A, Willett WC (1994) Are body iron stores related to risk of coronary heart disease? N Engl J Med 330: 1152-1153 [editorial]
51. Sullivan JL (1996) Iron versus cholesterol - perspectives on the iron heart disease debate. J Clin Epidemiol 49: 1345-1352
52. Salonen JT, Korpela H, Nyyssönen K, Porkkala E, Toumainen TP, Belcher JD, Jacobs DR, Salonen R (1995) Lowering of body iron stores by blood-letting and oxidation resistance of serum lipoproteins: a randomized cross-over trial in male smokers. J Intern Med 237: 161-168
53. Gillum RF, Sempos CT, Looker AC, Chien CY (1996) Serum transferrin saturation and stroke incidence and mortality in men and women: The NHANES I epidemiologic follow-up study. Am J Epidemiol 144: 59-68
54. Sempos CT, Gillum RF, Looker AC (1997) Iron and heart disease: A review of the epidemiologic data. In: Bendich A, Deckelbaum RJ (eds), Preventive nutrition: The comprehensive guide for health professionals. Humana Press Inc, Totowa, NJ
55. Takkunen H, Reunanen A, Knekt P, Aromaa A (1989) Body iron stores and the risk of cancer. N Engl J Med 320: 1013-1014 [Letter]
56. Ascherio A, Willett WC, Rimm EB, Giovannucci EL, Stampfer MJ (1994) Dietary iron and risk of coronary heart disease among men. Circulation 89: 969-974
57. Tzonou A, Lagiou P, Trichopoulou A, Tsoutsos V, Trichopoulos D (1998) Dietary iron and coronary heart disease risk: A study from Greece. Am J Epidemiol 147: 161-166
58. Klipstein-Grobusch K, Grobbee DE, den Breejien JH, Boeing H, Hofman A, Witterman JCM (1999) Dietary iron and risk of myocardial infarction in the Rotterdam Study. Am J Epidemiol 149: 421-428
59. Sullivan JL (1991) Blood donation may be good for the donor. Vox Sang 61: 161-164
60. Sullivan JL (1992) Stored iron and ischemic heart disease. Empirical support for the new paradigm. Circulation 86: 1036-1037
61. Finch CA, Cook JD, Labbe RF, Culala M (1977) Effect of blood donation on iron stores as evaluated by serum ferritin. Blood 50: 441-447
62. Meyers DG, Strickland D, Maloley PA, Seburg JJ, Wilson JE, McManus BF (1997) Possible association of a reduction in cardiovascular events with blood donation. Heart 78: 188-193
63. Tuomainen T-P, Salonen R, Nyyssönen K, Salonen JT (1997) Cohort study of relation between donating blood and risk of myocardial infarction in 2,682 men in eastern Finland. BMJ 314: 793-794
64. Salonen JT, Tuomainen T-P, Salonen R, Lakka TA, Nyyssönen K (1998) Donation of blood is associated with reduced risk of myocardial infarction. Am J Epidemiol 148: 445-451
65. Merk K, Mattsson B, Mettsson A, Holm G, Gullbring B, Björkholm M (1990) The incidence of cancer among blood donors. Int J Epidemiol 19: 505-509
66. Ford I (1997) Is blood donation good for the donor. Heart 78: 107 [Editorial]
67. Gillum RF (1997) Body iron stores and atherosclerosis. Circulation 96: 3261-3263 [Editorial]
68. Gordon T (1974) Hazards in the use of the logistic function with special reference to data from prospective cardiovascular disease studies. J Chron Dis 27: 97-102
69. McGee D, Reed D, Yano K (1984) The results of logistic regression analyses when the variables are highly correlated: An empirical example using diet and CHD incidence. J Chron Dis 37: 713-719
70. Sempos CT, Liu K, Ernst ND (1999) Food and nutrient exposures: what to consider when evaluating epidemiologic evidence. Am J Clin Nutr 69(suppl): 1330s-1338s
71. Miller M, Hutchins GM (1994) Hemochromatosis, multiorgan hemosiderosis, and coronary heart disease. JAMA 272: 231-233
72. Barton JC, McDonnell SM, Adams PC, Brissot P, Powell LW, Edwards CQ, Cook JD, Kowdley KV (1998) Managment of hemochromatosis. Ann Intern Med 129: 932-939
73. Felitti VJ (1999) Hemochromatosis: A common, rarely diagnosed disease. The Permanente J 3: 10-20
74. Yang Q, McDonnell SM, Khoury MJ, Cono J, Parrish RG (1998) Hemachromatosis-associated mortality in the United States from 1979-1992: An analysis of multiple-cause mortality data. Ann Intern Med 129: 946-953
75. Corti M-C, Gaziano M, Hennekens CH (1997) Iron status and risk of cardiovascular disease. Ann Epidemiol 7: 62-68
76. Gordeuk VR, Devee Boyd R, Brittenham GM (1986) Dietary iron overload persists in rural Sub-Saharan Africa. Lancet 1: 1310-1313
77. Lynch SR (1995) Iron overload: Prevalence and impact on health. Nutr Rev 53: 255-260
78. Keys A (1967) Dietary epidemiology. Am J Clin Nutr 20: 1151-1157
79. Stamler J (1967) Lectures on Preventive Cardiology. Grune and Stratton, New York
80. Stamler J (1978) Lifestyles, major risk factors, proof, and public policy. Circulation 58: 3-19
81. Consensus Conference (1985) Lowering Blood Cholesterol to prevent heart disease. JAMA 253: 2080-2086
82. Weintraub WS, Wenger NK, Parthasaranthy S, Brown WV (1996) Hyperlipidemia versus iron overload and coronary heart disease: Yet more arguments on the cholesterol debate. J Clin Epidemiol 49: 1353-1356
83. Zock PL, Katan MB (1998) Diet, LDL oxidation, and coronary artery disease. Am J Clin Nutr 68: 759-760 [Editorial]
84. Iribarren C, Folsom AR, Jacobs DR, Gross MD, Belcher JD, Eckfeldt JH (1997) Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. Arterioscler Thromb Vasc Biol 17: 1171-1177
85. van de Vijver LPL, Kardinaal AFM, van Duyvenvoorde W, Kruijssen DACM, Grobee DE, van Poppel G, Princen HMG (1998) LDL oxidation and extent of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 18: 193-199
86. Halevy D, Thiery J, Nagel D, Arnold S, Erdmann E, Höfling B, Cremer P, Seidel D (1997) Increased oxidation of LDL in patients with coronary artery disease is independent from dietary vitamins E and C. Arterioscler Thromb Vasc Biol 17: 1432-1437
87. Salonen JT, Nyyssönen K, Salonen R, Porkkala-Sarataho E, Toumainen T-P, Diczfalusy U, Björkhem I (1996) Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation 94: 1-93 [Abstract]
88. Uusitupa MIJ, Niskanen L, Luoma J, Vilja P, Mercuri M, Rauramaa R, Ylä-Herttuala S (1996) Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes. Arterioscler Thromb Vasc Biol 16: 1236-1242
89. Maggi E, Chiesa R, Melissano G, Castellano R, Astore D, Grossi A, Finardi G, Bellomo G (1994) LDL oxidation in patients with severe carotid athersclerosis. A study of in vitro and in vivo oxidation markers. Arterioscler Thromb 14: 1892-1899
90. Iribarren C, Sempos CT, Eckfeldt JH, Folsom A (1998) Lack of association between ferritin level and measures of LDL oxidation. The ARIC Study. Atherosclerosis 139: 189-195
91. Craig WY, Poulin Se, Palomaki GE, Neveux LM, Ritchie RF, Ledue TB (1995) Oxidation-related analytes and lipid and lipoprotein concentrations in adults. Arterioscler Thromb Vasc Biol 15: 733-739
92. Sempos CT, Looker AC, Gillum RF (1996) Iron and heart disease: The epidemiologic data. Nutr Rev 54: 73-84
93. Ferns GAA, Lamb DJ, Taylor A (1997) The possible role of copper ions in atherosclerosis: the Blue Janus. Atherosclerosis 133: 130-152
94. Derstine JL, Beard JL, Kris-Etherton P (1999) Analysis of iron status and dietary heme iron intake in association with risk of cardiovascular disease. FASEB J 13: A572 [Abstract #450.2]
95. Witzum JL (1994) The oxidation hypothesis of atherosclerosis. Lancet 344: 793-795
96. Custer EM, Finch CA, Sobel RE, Zettner A (1995) Population norms for serum ferritin. J Lab Clin Med 126: 88-94
97. Danesh J, Collins R, Appleby P, Peto R (1998) Fibrinogen, C-reactive protein, albumin or white cell count: meta-analysis of prospective studies of coronary heart disease. JAMA 279: 1477-1482
98. Dormandy TL (1978) Free-radical oxidation and antioxidants. Lancet 1: 647-650
99. National Cholesterol Education program (1991) Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. Circulation 83: 2154-2232
100. Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (1993) Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 269: 3015-3023
101. Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. (1997) The Sixth Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. 157: 2413-2446
102. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K (1998) Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 140: 199-270